Vetmarket - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 7,764,801 | 10,486,613 | 11,623,611 | 13,111,676 | 13,997,765 | 22,002,428 | 26,467,303 | 22,732,680 |
| Profit before tax | 66,178 | 217,212 | 36,637 | -255,474 | -319,317 | 1,188,250 | 899,634 | 543,655 |
| Net profit | 52,301 | 175,288 | 29,126 | -220,211 | -285,857 | 1,006,112 | 753,761 | 447,642 |
| Equity | 1,813,569 | 1,988,857 | 2,017,983 | 1,797,772 | 1,511,915 | 2,518,027 | 3,271,788 | 3,719,430 |
| Liabilities | 2,741,742 | 3,779,042 | 3,424,860 | 4,377,895 | 4,726,733 | 4,957,413 | 4,090,185 | 3,756,334 |
| Non-current assets | 1,142,687 | 1,066,571 | 1,153,724 | 1,058,786 | 885,256 | 643,785 | 707,526 | 480,399 |
| Current assets | 3,405,525 | 4,696,712 | 4,288,720 | 5,111,638 | 5,353,230 | 6,831,655 | 6,654,447 | 7,039,956 |
| Total assets | 4,548,212 | 5,763,283 | 5,442,444 | 6,170,424 | 6,238,486 | 7,475,440 | 7,361,973 | 7,520,355 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,104,817 | 2,944,431 | 2,238,140 |
| Social insurance contributions | - | - | - | - | - | 362,449 | 391,652 | 392,445 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +6.9% | +35.1% | +10.8% | +12.8% | +6.8% | +57.2% | +20.3% | -14.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 1.1% | 3.0% | 0.5% | -3.6% | -4.6% | 13.5% | 10.2% | 6.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 2.9% | 8.8% | 1.4% | -12.2% | -18.9% | 40.0% | 23.0% | 12.0% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.7% | 1.7% | 0.3% | -1.7% | -2.0% | 4.6% | 2.8% | 2.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.9% | 2.1% | 0.3% | -1.9% | -2.3% | 5.4% | 3.4% | 2.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.5 | 1.9 | 1.7 | 2.4 | 3.1 | 2.0 | 1.3 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 244,561 | 274,758 | 248,191 | 238,034 | 256,448 | 460,784 | 574,336 | 482,818 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vetmarket - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-16 | 2025-12-22 | 154.55 |
| 2025-11-18 | 2025-11-23 | 220.78 |
| 2025-10-16 | 2025-10-16 | 100.05 |
| 2023-05-02 | 2023-05-11 | 0.39 |
| 2023-04-18 | 2023-04-28 | 0.39 |
| 2023-03-16 | 2023-04-11 | 0.42 |
| 2023-02-06 | 2023-02-12 | 0.38 |
| 2023-01-17 | 2023-02-03 | 0.38 |
| 2022-12-16 | 2023-01-10 | 0.40 |
| 2022-07-18 | 2022-07-19 | 7.42 |
| 2022-04-25 | 2022-05-09 | 0.08 |
| 2022-04-19 | 2022-04-24 | 0.07 |
| 2022-01-28 | 2022-02-10 | 0.41 |
| 2021-10-18 | 2021-10-19 | 276.31 |
Vetmarket - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-08 | 2026-03-12 | 0.48 |
| 2026-03-02 | 2026-03-07 | 1863.5 |
| 2026-01-13 | 2026-01-19 | 19.68 |
| 2026-01-10 | 2026-01-12 | 19.23 |
| 2024-09-29 | 2024-10-09 | 8.59 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vetmarket, UAB (code 302512874) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €22.73M and net profit of €447.6K, with a profit margin of 2.0%. Revenue declined by 14.1% year on year, although the two-year comparison still shows 3.3% growth versus 2023. Profitability weakened over the period: net profit was €1.01M in 2023, €753.8K in 2024 and €447.6K in 2025. Balance sheet indicators remained broadly stable, with total assets of €7.52M in 2025, equity of €3.72M and liabilities of €3.76M. The equity ratio was 49.5%, and debt-to-equity stood at 1.01. Efficiency ratios indicate solid asset use, with asset turnover at 3.02x, ROE at 12.0% and ROA at 6.0%. Revenue per employee was €483.7K and profit per employee was €9.5K, pointing to a sizeable turnover base with moderate profitability in the latest financial year.